A role for endocannabinoids in indomethacin-induced spinal antinociception
- 22 October 2002
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 454 (2-3) , 153-163
- https://doi.org/10.1016/s0014-2999(02)02485-8
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002
- Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significanceProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Mechanisms of anandamide‐induced vasorelaxation in rat isolated coronary arteriesBritish Journal of Pharmacology, 2001
- Characterization of EP receptor subtypes responsible for prostaglandin E2‐induced pain responses by use of EP1 and EP3 receptor knockout miceBritish Journal of Pharmacology, 2001
- Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolaseBritish Journal of Pharmacology, 2000
- New NO-Donors with Antithrombotic and Vasodilating Activities, X: Antiplatelet and Antithrombotic Effects of 3-Methylsydnone-5-nitrosimine (RE 2047) in Combination with ASA, Pentoxifylline, and TiclopidineArchiv der Pharmazie, 1995
- Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibitionCellular and Molecular Life Sciences, 1991
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983
- The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and catsPain, 1977
- Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.BMJ, 1975